Inventor
BOONE THOMAS CHARLES
US17 patents
⚠️ This page may combine multiple inventors who share the name “BOONE THOMAS CHARLES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
16 patentsUS7511012B2Mar 31, 2009
Myostatin binding agents
AMGEN INC47 citations95
US7488590B2Feb 10, 2009
Modified peptides as therapeutic agents
AMGEN INC33 citations92
US7008924B1Mar 7, 2006
VGF fusion polypeptides
AMGEN INC40 citations92
US6500429B2Dec 31, 2002
Antibodies against analogs of brain-derived neurotrophic factor
AMGEN INC19 citations90
US10308704B2Jun 4, 2019
Isolated nucleic acid molecules encoding stabilized receptor polypeptides and uses thereof
AMGEN INC12 citations83
US9562108B2Feb 7, 2017
Carrier immunoglobulins
AMGEN INC8 citations83
US8920798B2Dec 30, 2014
Myostatin binding agents, nucleic acids encoding the same, and methods of treatment
AMGEN INC9 citations83
US7348162B2Mar 25, 2008
Nucleic acids encoding fibroblast growth factor receptor-like proteins and uses thereof
AMGEN INC13 citations80
US6723701B2Apr 20, 2004
Protein analogs of brain-derived neurotrophic factor
AMGEN INC11 citations71
US11685770B2Jun 27, 2023
Stabilized receptor polypeptides and uses thereof
AMGEN INC0 citations62
US9562107B2Feb 7, 2017
Carrier immunoglobulins
AMGEN INC1 citations61
US6211150B1Apr 3, 2001
Analogs of cationic proteins
AMGEN INC1 citations60
US10336820B2Jul 2, 2019
Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof
AMGEN INC0 citations51
US10189912B2Jan 29, 2019
Carrier immunoglobulins
AMGEN INC0 citations50
US6468970B2Oct 22, 2002
Analogs of NT-3
AMGEN INC0 citations49
US6271364B1Aug 7, 2001
Analogs of NT-3
AMGEN INC0 citations49